Professor Anne MacGregor Honorary Professor, Centre for Neuroscience, Surgery and Trauma, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry. Headache and migraine increase in prevalence during menopause but often go undiagnosed and...
- July 13, 2022
Robert D. Langer Robert D. Langer, MD, MPH, University of California, San Diego, USA Prior to the unexpected early termination of the Women’s Health Initiative (WHI) trial of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), the prevailing view was...
- July 13, 2022
Professor Beverley Vollenhoven Monash University Perimenopausal bleeding is not always abnormal, the key is to understand when it is abnormal and to investigate appropriately. The treatment is often hormonal and this presentation will discuss these options.
- July 13, 2022
Professor Darren Russell Sexual health physician and the Director of Sexual Health at Cairns Hospital There is emerging evidence that in Australia women in their midlife are developing some sexually transmitted infections (STIs) at increasing rates compared to previous years,...
- July 13, 2022
Professor Marie Bismark Melbourne School of Population and Global Health Healthcare does tremendous good but can also cause harm. Patient complaints provide an opportunity to address misunderstandings, re-establish trust, and improve the quality and safety of care. However, complaints can...
- July 5, 2022
Professor Rodney Baber University of Sydney / Royal North Shore Hospital National and International Guidelines consistently state that the principal indication for the use of menopausal hormone therapy (MHT) is the alleviation of troublesome menopausal vasomotor symptoms and that MHT...
- July 5, 2022
Professor Rodney Baber University of Sydney / Royal North Shore Hospital Although more common in men than in women cardiovascular disease (CVD) remains the leading cause of death for women globally. A beneficial effect of estrogen on surrogate markers of...
- July 5, 2022
Karen Magraith General Practice Plus, Hobart Menopause is defined as the final menstrual period, with perimenopause being the time from when the cycle starts to change until a year after the final menstrual period. Normally women experience menopause between 45...
- July 5, 2022
Professor Pauline Maki The University of Illinois at Chicago Complaints of brain fog are common in the years leading up to the menopause transition and thereafter. Longitudinal studies validate these complaints in showing measurable and reliable changes in certain cognitive...
- July 5, 2022
Management of anxiety and depression in midlife woman – the role of MHT and psychotropic medications
Professor Jayashri Kulkarni Alfred Health and Monash University In addition to numerous somatic symptoms, one in three women will experience significant psychological changes during the transition into menopause. Previous studies have demonstrated that women are not only at an increased...
- July 5, 2022